Strategic partnerships Form Health is actively expanding through partnerships and employer-focused programs, including a recent collaboration with SmithRx to deliver sustainable GLP-1 coverage. This signals a ready pathway for multi-party deals with PBMs, employers, and health plan networks.

Enterprise credibility Recognition from Fast Company as an innovative company and inclusion on Inc.'s Best Workplaces list strengthen Form Health's credibility with potential enterprise clients, suggesting a lower sales risk when targeting large employers and health plans.

Integrated care The expansion from obesity care into a single cardiometabolic solution (including diabetes care) creates cross-sell opportunities with employers seeking unified, physician-supervised programs that cover multiple conditions under one package.

Financial momentum Reported revenue in the tens of millions plus a substantial funding runway provide a positive signal for scale-oriented buyers and investors, indicating capacity to absorb large-scale contracts and long-term value for enterprise partnerships.

Healthcare network fit In-network status with national health plans and a focus on evidence-based, FDA-approved medications aligns well with employers and health plans seeking compliant, cost-conscious obesity and cardiometabolic care solutions that demonstrate ROI.